ObsEva (NASDAQ:OBSV) Coverage Initiated by Analysts at StockNews.com

StockNews.com assumed coverage on shares of ObsEva (NASDAQ:OBSV) in a research report report published on Wednesday morning. The firm issued a hold rating on the stock.

ObsEva Stock Performance

The stock’s 50 day moving average is $0.01 and its 200 day moving average is $0.04. ObsEva has a 1 year low of $0.08 and a 1 year high of $2.14. The stock has a market capitalization of $7.94 million, a price-to-earnings ratio of -0.11 and a beta of 0.68.

About ObsEva

ObsEva SA is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic treatments for women’s reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. The company was founded by Ernest Loumaye and André Chollet on November 14, 2012 and is headquartered in Geneva, Switzerland.